The OCRP Pilot Award supports the exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. The proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models), and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s).
The OCRP Pilot Award – Early Detection or Prevention Option focuses specifically on innovative concepts or theories that will lead to major advances in the fields of early ovarian cancer detection or ovarian cancer prevention. The proposed research must demonstrate a clear focus on investigating early detection and prevention strategies in ovarian cancer
Deadlines:
• Required Pre-Application Deadline: June 12, 2025
• Application Submission Deadline: September 11, 2025
To meet the intent of the funding opportunity, applications for the FY25 OCRP Pilot Award must address a critical component of one of the Areas of Emphasis listed below:
• Understand the basic biology and etiology of ovarian cancer initiation, progression, metastasis, recurrence, genetics, and other critical events.
• Develop novel therapeutic strategies for treatment.
• Identify and implement strategies to improve survivorship and quality of life.
• Improve precision medicine.
Applications for the FY25 OCRP Pilot Award – Early Detection or Prevention Option must address one of the Areas of Emphasis listed below:
• Investigate innovative approaches for ovarian cancer prevention.
• Identify and develop new strategies for screening, early-stage detection, accurate diagnosis, and prognosis.
Investigators at the level of postdoctoral fellow or clinical fellow (or equivalent) and above may be named by the organization as the Principal Investigator (PI) on the application.
An investigator may be named on only one Pilot Award application as a PI.
Individuals affiliated with an eligible organization are eligible to be named as PI regardless of ethnicity, nationality, or citizenship status.
The Congressionally Directed Medical Research Programs (CDMRP) expects to allot approximately $3.15 million (M) to fund approximately nine Pilot Award applications with total cost caps of $0.35M. The maximum period of performance is 2 years. It is anticipated that awards made from this fiscal year 2025 (FY25) funding opportunity will be funded with FY25 funds, which will expire for use on September 30, 2031. Awards supported with FY25 funds will be made no later than September 30, 2026.